The electronic Common Technical Document (eCTD) has changed how pharmaceutical and life sciences companies submit regulatory applications worldwide. This standardized format simplifies the submission process for drug and medical device registration. Major regulatory agencies like the FDA, EMA, NMPA, and Health Canada now accept it.
Here’s the thing: successful eCTD submissions need more than technical accuracy. They require knowledge of region-specific compliance rules and careful planning. Many submissions also need multi-language documentation that meets both linguistic and technical standards. If you’re tackling your first eCTD submission or refining your current eCTD submission process, this guide walks you through the essential steps to getting your submission right the first time.
The regulatory landscape is always changing. In 2024, the FDA started accepting eCTD version 4.0 for new applications. Japan’s PMDA plans to make eCTD v4.0 mandatory by 2026. Staying ahead of these updates is key to successful eCTD publishing and long-term compliance.
What Are the Regional Differences of eCTD?
eCTD is accepted worldwide, but each region has its own rules. Getting these differences wrong early on can lead to costly delays and painful resubmissions later.
United States (FDA)
The FDA requires eCTD submissions for most new drug applications, laying out specific technical rules in its guidance documents. Since September 2024, they have supported both eCTD v3.2.2 and the newer v4.0 format. Your submission must follow the FDA’s electronic submission standards, including:
- Specific file naming rules and checking requirements
- Physical media (DVDs) for submissions larger than 10 GB
- Electronic Submissions Gateway (ESG) for smaller files
- Pre-assigned application numbers before submission
Europe (EMA)
The European Medicines Agency takes a stricter approach, making the eCTD format mandatory for centralized procedures according to its eSubmission guidelines.
They have added extra requirements for certain sections. This is especially true for risk management plans and pediatric investigation plans.
Key EMA requirements include:
- Specific metadata elements not found in other regions
- EU M1 v3.1 and validation criteria v8.0 (mandatory from March 2025)
- Electronic Application Forms (eAF) for all submissions
- Tracking tables as annexes to cover letters
China (NMPA)
China’s National Medical Products Administration (NMPA) expanded its eCTD rules in January 2025. These now cover more drug categories than before.
They accept eCTD submissions, but every document must be translated into Chinese with no exceptions.
The NMPA requirements include:
- Complete Chinese translation of all documents
- Unique requirements for traditional Chinese medicine products
- Specific data requirements not needed elsewhere
- Online portal submission when possible
- CD-ROM submission with paper backup within 5 working days
Japan (PMDA)
Japan’s approach is unique. They have adopted eCTD but still require specific Japanese clinical data, often with detailed bridging studies.
The PMDA plans to make eCTD v4.0 mandatory by 2026, and its lifecycle management process works differently from other agencies.
Japanese requirements include:
- Each regulatory activity starts a completely new dossier lifecycle
- Specific Japanese clinical data requirements
- Detailed bridging studies are often required
- CTD-DMF format for drug master files
Canada (Health Canada)
Health Canada uses a similar eCTD structure but adds its own rules. These include bilingual labeling and Canada‑specific safety data.
All submissions must go through their Electronic Submissions Gateway (ESG). They also require signed attestation forms before accepting any file.
Canadian specifics include:
- Bilingual labeling requirements (English/French)
- Signed attestation forms are mandatory
- Electronic Submissions Gateway (ESG) submission
- Canadian-specific safety data requirements
Here is the bottom line: regional differences make a single approach almost impossible for global eCTD submissions. Each submission must be tailored to meet the specific rules of each regulatory agency while still keeping the overall eCTD structure intact.
Step-by-Step Guide to Preparing Your eCTD for Submission
1: Master the eCTD Structure
Don’t jump into document preparation until your team gets the five-module eCTD structure:
- Module 1: Regional administrative information
- Module 2: Summaries and overviews
- Module 3: Quality data
- Module 4: Nonclinical study reports
- Module 5: Clinical study reports
Each module connects to the others in specific ways. Take Module 2. It needs to effectively summarize and cross-reference information from Modules 3, 4, and 5. If you overlook these connections, it could lead to unnecessary regulatory inquiries or delays.
On paper, the structure appears simple, yet the complexity lies in the details. Module 1 varies dramatically between regions. What works perfectly for FDA submissions might fail for EMA or NMPA submissions. Spend time reviewing the complete Table of Contents requirements for each target agency. It’s time well invested.
2: Get Regional Requirements Sorted Early
A common oversight among companies is waiting until the document gathering stage to address regional differences. Don’t be one of them. Research specific requirements for each target market during your planning phase. This covers:
- Language requirements and translation needs
- Local data requirements and clinical expectations
- Region-specific formatting or content expectations
- Submission portal preferences and technical specs
- Metadata and validation requirements
Build a complete requirements matrix showing what each regulatory agency expects. Getting these requirements nailed down early prevents last-minute panic and gives you adequate preparation time.
Consider this example: if you’re planning submissions to both the FDA and NMPA, you’ll need Chinese translation time, different metadata requirements, and varying clinical data expectations. Some companies underestimate this timeline by 6-12 months. Don’t let that be you.
3: Assemble Your Dream Team
Successful eCTD submissions need different types of expertise, and they are hard to handle alone. Your core team should include:
- Regulatory affairs specialists familiar with target markets
- Medical writers experienced in regulatory documentation
- Project managers skilled in complex submissions
- Quality assurance professionals who understand eCTD checking requirements
- Translation and localization specialists for global submissions
- IT professionals who understand eCTD publishing software
Bring eCTD translation and localization specialists into the process early, especially for global submissions. Language needs go beyond basic translation. Regulatory documents need the right terminology and cultural adjustments to meet local rules.
Smart companies also bring in IT professionals who know eCTD publishing software. They can fix technical issues during submission. Having this expertise in house saves time when deadlines are tight.
4: Build in Realistic Timelines
Preparing an eCTD typically takes longer than most companies anticipate. Your realistic timeline should include the following factors:
- Document drafting and internal reviews
- eCTD translation and localization
- Quality control checks and technical validation
- Potential review rounds and revisions
- Buffer time for unexpected challenges
Buffer time is not optional. It is essential. Regulatory agencies often update requirements. Translation projects can reveal missing content. Technical checks may find structural issues.
A timeline with built-in flexibility helps avoid last-minute quality problems that could sink your submission. Many industry professionals suggest adding 25–30% buffer time to initial estimates. Their advice is worth following.
5: Get Your Documentation House in Order
How you organize your documents can have a big impact. It can even decide the success of your eCTD submission. Start by setting up:
- Clear naming rules that comply with regulatory requirements
- Consistent naming across all modules and regions
- Master document inventory tracking all files
- Version numbers and approval status for every document
- Strong version control procedures
Strong version control is essential. It keeps outdated documents from slipping into your submission.
Investing in expert eCTD authoring software helps maintain the correct structure and supports technical checks. This investment is worth the cost.
6: Navigate Translation and Localization Like a Pro
Translation requirements vary wildly between regions, and the scope goes far beyond simple language conversion. Regulatory translation demands:
- Subject matter expertise in regulatory terminology
- Familiarity with local regulatory language preferences
- Understanding of cultural nuances affecting acceptance
- Consistency across all translated documents
- Adaptation of units, dates, and regulatory references
Professional eCTD translation services understand these complexities and can maintain consistency across all translated documents.
eCTD translation is not just about changing English into another language.
It means adjusting the entire submission to meet the rules of the local regulatory body while keeping the science accurate. This process often uncovers gaps in the original documents that need fixing before submission.
7: Master Quality Control and Validation
Quality control for eCTD submissions works on multiple levels, including:
- Content review: Scientific accuracy and regulatory compliance
- Technical checking: Proper eCTD structure and file formatting
- Language QA: Translation accuracy and consistency
- Automated tools: Quick identification of technical issues
- Manual review: Content mismatches and regulatory appropriateness
Use both automated tools and manual review. Automated tools quickly find issues like broken links and formatting errors. Manual review checks content accuracy and ensures it meets regulatory rules. Using both methods gives you a complete and reliable quality check.
8: Submit Through the Right Portal
Each regulatory agency has its own submission portals and procedures. These differ from one another, so it is important to get familiar with:
- Technical requirements for each target market
- Submission windows and confirmation processes
- Test environments for pre-submission verification
- Backup plans for technical difficulties
- Alternative submission methods and support contacts
Here’s what you need to know for major agencies:
- FDA: Physical media for submissions >10 GB, ESG for smaller files
- EMA: Their gateway system with specific validation rules
- NMPA: Online submission through the drug review platform is preferred
- Health Canada: ESG submission with mandatory attestation forms
Make sure you understand these requirements long before your submission deadline.
Conclusion
Preparing for an eCTD submission requires careful planning. It also demands an understanding of regional requirements and organized document preparation.
Success depends on mastering the technical eCTD format. It also requires meeting each regulatory agency’s specific expectations.
Working with experienced partners is essential because of the complexity of global regulatory requirements. These partners need to understand the scientific and technical aspects of eCTD submissions. Accurate translation and localization are critical for meeting language and regulatory standards across different markets.
The eCTD submission process continues to evolve. Agencies like the FDA now support eCTD v4.0. Others are planning mandatory transitions by 2026. Staying current with regulatory changes is essential for long-term compliance.
Ready to Nail Your eCTD Submission Success?
At EC Innovations, we specialize in eCTD translation and localization services for life sciences companies. Our team combines deep regulatory knowledge with language expertise. We help your submissions meet the highest standards across global markets. If you need support with document translation, regional localization, or complete eCTD preparation guidance, experienced professionals can help you navigate the complexities of global regulatory submissions. For more information about supporting your next eCTD submission across target markets, contact us.
